U.S. Markets open in 4 hrs 16 mins

Aveanna Healthcare Holdings Inc. (AVAH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.44-0.46 (-4.65%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.90
Open9.82
Bid9.43 x 800
Ask9.47 x 800
Day's Range9.24 - 9.95
52 Week Range9.24 - 13.00
Volume887,779
Avg. Volume854,098
Market Cap1.739B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Editor's Pick
    Yahoo Finance Video

    Bain Capital Private Equity sees more opportunity in healthcare

    Bain Capital Private Equity's Managing Director Devin O'Reilly explains why his firm sought out its new investment in PartSource and other investment areas Bain likes in the healthcare space.

  • What Kind Of Investors Own Most Of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)?
    Simply Wall St.

    What Kind Of Investors Own Most Of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)?

    If you want to know who really controls Aveanna Healthcare Holdings Inc. ( NASDAQ:AVAH ), then you'll have to look at...

  • Aveanna Healthcare stock slips as most analysts initiate will bullish rating, but a lead underwriter's analyst is neutral
    MarketWatch

    Aveanna Healthcare stock slips as most analysts initiate will bullish rating, but a lead underwriter's analyst is neutral

    Shares of Aveanna Healthcare Holdings Inc. dropped% in afternoon trading Monday, even as almost all of the analysts who started covering the home-care company recommended buying. The stock has closed every day, since it went public on April 29, below its initial public offering price of $12. Of the 11 analysts surveyed by FactSet, 10 initiated Aveanna with the equivalent of buy ratings, while the average price target of $15.50 was 29.2% above the IPO price. Meanwhile, analyst Lisa Gill at J.P. Morgan, which was one of the lead underwriters of Aveanna's IPO, started the company at neutral with a $14 stock price target. Despite her less-than-enthusiastic stance, Gill said Aveanna has "ample room for growth" with its business segments, as it has a market share of less than 1% of the $107 billion total addressable market (TAM). She wrote that she is "constructive" on Aveanna's potential to achieve high growth by increasing market share and through acquisitions. Meanwhile, she believes current "discounted valuation" is a result of Aveanna's higher leverage and lower organic growth rate versus its peers. Since going public, the stock has closed in a range of a closing high of $11.80 on May 3 and a low of $10.06 on May 13. The stock's decline comes on a day that the Renaissance IPO ETF rallied 1.9% and the S&P 500 climbed 1.2%.